Anticoagulated Whole Human Blood Units
Standard 450-500mL units of human whole blood treated with CPD or CPDA-1 anticoagulant, stored in PVC blood bags for emergency transfusions. Classified under HTS 3002.90.52.10 as unmodified whole human blood for therapeutic transfusion purposes.
Import Duty Rates by Country of Origin
Alternative Classifications
This product could be classified differently depending on its characteristics or intended use.
If modified or biotech-processed
Biotechnologically modified whole blood or those with additives beyond standard anticoagulants fall under 'other' modified blood products.
If imported in medical device blood collection kits
When sold as a complete blood collection and storage system for retail/medical use, it may classify as a medical appliance rather than bulk blood.
If it's human antisera derived from blood
Antisera produced from human blood plasma shifts classification from whole blood to immunological products.
Not sure which classification is right?
The Tariff Assistant works through the GRI rules on your specific product to reach the right HTS code — and can price the duty on it in the same conversation.
Import Tips & Compliance
• Include AABB or equivalent accreditation certificates and lot-specific testing results for HIV, HBV, HCV to meet FDA import requirements
• Use IATA-compliant shipping with insulated containers and real-time temperature monitoring to preserve 35-day shelf life
• Declare exact volume and expiration date accurately; mismatches lead to CBP holds and potential product loss
Related Products under HTS 3002.90.52.10
Whole Human Blood for Transfusion
Whole human blood collected from donors, anticoagulated, and prepared for direct transfusion into patients experiencing acute blood loss or anemia. It falls under HTS 3002.90.52.10 as whole human blood intended for therapeutic uses without separation into components like plasma or platelets.
O-Negative Whole Human Blood for Emergencies
Universal donor O-negative whole human blood, group-typed and cross-matched, for immediate use in trauma cases without compatibility testing. HTS 3002.90.52.10 covers this as therapeutic whole human blood not separated into fractions.
Irradiated Whole Human Blood for Immunocompromised Patients
Gamma-irradiated whole human blood to prevent graft-vs-host disease in transplant or cancer patients, qualifying as therapeutic whole human blood under HTS 3002.90.52.10.
Leukoreduced Whole Human Blood
Whole human blood with leukocytes filtered to <5x10^6 per unit to reduce transfusion reactions, still classified as whole blood under HTS 3002.90.52.10 since primary components remain intact.